Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Gene Synthesis, Genome Engineering), Application(Tissue Regeneration, Biofuel, Consumer Care, Food & Agriculture, Environmental) and Region - Global Forecast to 2026
[377 Pages Report] The global synthetic biology market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period. Factors such as a wide range of applications of synthetic biology, the rising R&D funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market. However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 impact on the synthetic biology market
Many established pharmaceutical and biopharmaceutical companies, along with players of the synthetic biology market, have stepped forward to contribute to worldwide research efforts by providing synthetic biology for developing test kits, treatments, and vaccines to target the infection caused by the coronavirus. Synthetic biology is highlighted as one of the emerging technologies in a report from the European Parliament. It can fight the COVID-19 pandemic. The National Institute of Health in the US has also identified synthetic biology as one way to speed up vaccine development. Synthetic biology technologies have the potential to transform the development and production of vaccines, therapeutics, and diagnostics by utilizing their engineering approaches built on a variety of information (genomic sequences, sequence annotations, enzyme properties, metabolic models, lab protocols, algorithms, and scientific knowledge). For example, DNA- and mRNA-based vaccine technologies can ease the development and production of vaccines. These vaccines consist of synthetic nucleotide strands that trigger the formation of proteins via the individuals own cells, thereby inducing an immune response. The availability of viral sequence data can thus be rapidly translated into vaccine candidates. This has enabled ventures such as Moderna and Inovio to rapidly move into clinical development.
Global Synthetic Biology Market Dynamics
DRIVER: Rising R&D funding and growing initiatives in synthetic biology
The R&D sector has conventionally remained capital-intensive due to long development periods and approval cycles. Governments recognize R&D as a crucial investment for the progress of any country, international competitiveness, and public benefit. Due to this, R&D expenditure and funding have witnessed a steady increase over the years. According to Business Wire (September 2020), the R&D spending on the life sciences industry surged 22% from 2018 to 2019. Pharmaceutical and biotechnology companies invest heavily in research to develop breakthrough molecules to cater to the growing needs of the healthcare industry and combat new diseases. The global pharmaceutical R&D sector accounts for about 80% of the overall R&D expenditure in the life sciences industry.
RESTRAINT: Biosafety, biosecurity, and ethical concerns
One important biosafety concern in synthetic biology is the intentional or unintentional release of synthetic organisms into the environment during research and other applications. Synthetic microbes, when released into the environment, can mutate or interact with other organisms, resulting in crossbreeding with natural organisms and creating bio errors. This can threaten the ecosystem of natural organisms. The formation of antibiotic-resistant superbugs is another major biosafety concern. In recent years, the European Union (EU) has funded several research efforts on the environmental impact of deliberately released genetically engineered microbes for plant growth or bioremediation.
OPPORTUNITY: Rise in the need for fuel alternatives
With the increasing fuel consumption and growing concerns over energy security, sustainability, and climate change, biofuels are gaining significant importance. Around 150 billion tons of biomass is generated annually across the globe. Currently, edible commodities such as maize, sugarcane, and vegetable oil are being used to produce biofuels. This practice has initiated a debate on food versus fuel. However, these issues are being addressed due to the emergence of second-generation biofuels that are produced from renewable, cheap, and sustainable feedstocks such as citrus peel, corn stover, sawdust, bagasse, straw, and rice peel. This is subsequently paving the way for the application of synthetic biology techniques in the development of renewable energy.
The oligonucleotides & synthetic DNA segment dominated the synthetic biology market in 2020.
On the basis of tool, the synthetic biology market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. In 2020, oligonucleotides & synthetic DNA accounted for the largest share of synthetic biology market. This segment's large share can be attributed to factors such as rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications.
The medical applications segment is expected to grow at the highest CAGR during the forecast period.
Based on application, the synthetic biology market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications. The medical applications segment is expected to register the highest CAGR during the forecast period. Factors such as the extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies, is the primary driver for the medical applications segments growth.
North America was the largest regional market for synthetic biology market in 2020.
Geographically, the synthetic biology market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share of the synthetic biology market, followed by Europe and the Asia Pacific. The large share of the North American market is attributed to factors such as the increase in the number of well-established synthetic biology companies and research institutes in the US and Canada, a large number of ongoing research studies and growth of the overall healthcare sector on a global scale are among the few factors expected to contribute to the growth of this market. Substantial R&D spending is one of the key factors contributing to the increasing demand for synthetic biology tools and technologies among academic & research institutes and healthcare companies in North America.
Key Market Players
Key players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).
Scope of the report
|
Report Metric |
Details |
|
Market size available for years |
20192026 |
|
Base year considered |
2020 |
|
Forecast period |
20212026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Tool, Technology, Application, and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
|
Companies covered |
Thermo Fisher Scientific (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies (US), New England Biolabs (US), Royal DSM (Netherlands), OriGene Technologies (US), Genomatica (US), Illumina (US), and Scarab Genomics (US). |
This report categorizes the synthetic biology market into the following segments and subsegments:
Synthetic Biology Market, by Tool
- Oligonucleotides and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Synthetic Cells
- Chassis Organisms
- Xeno-nucleic Acids
Synthetic Biology Market, by Technology
- Gene Synthesis
- Genome Engineering
- Sequencing
- Bioinformatics
- Site-directed Mutagenesis
- Cloning
- Measurement and Modeling
- Microfluidics
- Nanotechnology
Synthetic Biology Market, by Application
- Medical Application
- Pharmaceuticals
- Drug Discovery and Therapeutics
- Cancer Detection & Diagnostics
- Other Drug Discovery and Therapeutic Applications
- Artificial Tissue and Tissue Regeneration
- Bio-synthesis
- Stem Cell Regulation
- Other Tissue and Tissue Regeneration Applications
- Industrial Applications
- Biofuel and Renewable Energy
- Biomaterials and Green Chemicals
- Industrial Enzymes, by Application
- Textile Industry
- Paper Industry
- Consumer Care Industry
- Skin Care & Cosmetics
- Other Consumer Care Products
- Other Industries
- Food & Agriculture
- Environmental Applications
- Bioremediation
- Biosensing
Recent Developments
- In January 2021, Novozymes launched Frontia GlutenEx. It would help wheat processors increase their gluten protein recovery and, at the same time, cut down on energy consumption.
- In February 2021, Merck partnered with BioNTech (Germany) to supply lipids for the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).
- In January 2021, Merck acquired AmpTec (Germany). With this acquisition, the company strengthened its product portfolio to develop and manufacture mRNA for utilizing vaccines, treatments, and diagnostics.
Frequently Asked Questions (FAQ):
What is the impact of COVID-19 on the synthetic biology market?
With broad applications of synthetic biology technologies in the development of diagnostics and treatments for the COVID-19 virus and increased research initiatives by private and government organizations, the overall synthetic biology market has shown a positive growth impact during this pandemic. With the current second wave and changing strains of the virus, it is predictable that the market would further grow in the near future.
Who are the key players in the synthetic biology market?
Key players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).
Which tools segment dominates in the synthetic biology market?
The oligonucleotides & synthetic DNA segment accounted for the largest share of the global synthetic biology market in 2020. This segment's large share can be attributed to factors such as rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications.
Which applications segment of the global synthetic biology market is expected to witness the highest growth?
Medical applications segment is expected to witness the highest growth. The high growth rate in this segment can be attributed to the factors such as the extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies.
What is the market for Synthetic Biology?
The global synthetic biology market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 53)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 57)
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 2 PRIMARY SOURCES
FIGURE 3 SYNTHETIC BIOLOGY MARKET: BREAKDOWN OF PRIMARIES
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 REVENUE SHARE ANALYSIS, 2020
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
FIGURE 6 SYNTHETIC BIOLOGY MARKET: CAGR PROJECTIONS, 20212026
FIGURE 7 SYNTHETIC BIOLOGY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 68)
FIGURE 9 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2021 VS. 2026 (USD MILLION)
FIGURE 10 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 11 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 GEOGRAPHIC ANALYSIS: SYNTHETIC BIOLOGY MARKET
4 PREMIUM INSIGHTS (Page No. - 71)
4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW
FIGURE 13 WIDE RANGE OF APPLICATIONS OF SYNTHETIC BIOLOGY DRIVES THE MARKET GROWTH
4.2 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION & COUNTRY (2020)
FIGURE 14 MEDICAL APPLICATIONS SEGMENT AND US ACCOUNTED FOR LARGE SHARES OF THE NORTH AMERICAN SYNTHETIC BIOLOGY MARKET IN 2020
4.3 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020
FIGURE 15 MEDICAL APPLICATIONS SEGMENT DOMINATED THE MARKET IN 2020
4.4 SYNTHETIC BIOLOGY MARKET: REGIONAL SNAPSHOT
FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 74)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 SYNTHETIC BIOLOGY MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Wide range of applications of synthetic biology
5.2.1.2 Rising R&D funding and growing initiatives in synthetic biology
FIGURE 18 R&D SPENDING OF PHRMA MEMBER COMPANIES, 20052019 (USD BILLION)
5.2.1.3 Declining cost of DNA sequencing and synthesizing
FIGURE 19 REDUCTION IN COST PER RAW MEGABASE OF DNA SEQUENCING (USD) (20102020)
5.2.1.4 Increasing investments in the market
5.2.2 RESTRAINTS
5.2.2.1 Biosafety, biosecurity, and ethical concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Rise in the need for fuel alternatives
5.2.3.2 Increase in the demand for protein therapeutics and personalized medicines
5.2.3.3 Growth in research on synthetic drugs and vaccines
5.2.4 CHALLENGES
5.2.4.1 Standardization of biological parts
5.3 IMPACT OF COVID-19 ON THE SYNTHETIC BIOLOGY MARKET
5.4 TECHNOLOGY ANALYSIS
TABLE 2 COMPARISON OF MODERN GENE EDITING TOOLS
5.5 ECOSYSTEM ANALYSIS
FIGURE 20 ECOSYSTEM ANALYSIS: SYNTHETIC BIOLOGY MARKET
TABLE 3 SUPPLY CHAIN ECOSYSTEM
5.6 PATENT ANALYSIS
FIGURE 21 PATENT APPLICATIONS FOR SYNTHETIC BIOLOGY, JANUARY 2010 DECEMBER 2020
5.7 PRICING ANALYSIS
TABLE 4 AVERAGE SELLING PRICE OF SYNTHETIC BIOLOGY PRODUCTS, (2020)
5.8 PORTERS FIVE FORCES ANALYSIS
TABLE 5 SYNTHETIC BIOLOGY MARKET: PORTERS FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.9 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS OF THE SYNTHETIC BIOLOGY MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
5.1 REGULATORY ANALYSIS
5.10.1 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
TABLE 6 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
6 SYNTHETIC BIOLOGY MARKET, BY TOOL (Page No. - 92)
6.1 INTRODUCTION
TABLE 7 SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 8 SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY REGION, 20192026 (USD MILLION)
TABLE 9 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 10 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 11 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 12 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
6.2.1 OLIGONUCLEOTIDES & SYNTHETIC DNA TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 13 OLIGONUCLEOTIDES & SYNTHETIC DNA: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 14 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 20192026 (USD MILLION)
TABLE 15 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 16 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 17 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.3 ENZYMES
6.3.1 DEVELOPMENT OF ENZYMES HELPED EVOLVE NEW THERAPIES FOR A RANGE OF DISEASES
TABLE 18 ENZYMES: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 19 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 20192026 (USD MILLION)
TABLE 20 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 21 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 22 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.4 CLONING TECHNOLOGY KITS
6.4.1 NEED FOR THE CREATION OF ARTIFICIAL DNA AND ASSEMBLY DRIVING THE GROWTH OF THE SEGMENT
TABLE 23 CLONING TECHNOLOGY KITS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 24 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 25 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 26 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 27 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.5 SYNTHETIC CELLS
6.5.1 SYNTHETIC CELLS TO ALLOW TAILORING BIOLOGICS TO INCREASE ADOPTION IN THE COMING YEARS
TABLE 28 SYNTHETIC CELLS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 29 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 30 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 31 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 32 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.6 CHASSIS ORGANISMS
6.6.1 INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL THE DEMAND FOR CHASSIS ORGANISMS
TABLE 33 CHASSIS ORGANISMS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 34 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 35 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 36 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 37 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.7 XENO-NUCLEIC ACIDS
6.7.1 XENO-NUCLEIC ACIDS BEING INCREASINGLY RESEARCHED DUE TO THE GROWING DEMAND FOR BREAKTHROUGH MEDICINES
TABLE 38 XENO-NUCLEIC ACIDS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 39 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 40 EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 41 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 42 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY (Page No. - 111)
7.1 INTRODUCTION
TABLE 43 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 44 SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY REGION, 20192026 (USD MILLION)
TABLE 45 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 46 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 47 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 48 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.2 GENE SYNTHESIS
7.2.1 GENE SYNTHESIS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 49 GENE SYNTHESIS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 50 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 51 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 52 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 53 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.3 GENOME ENGINEERING
7.3.1 INCREASING DEMAND FOR SYNTHETIC DNA AND GENES TO DRIVE THE MARKET GROWTH
TABLE 54 GENOME ENGINEERING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 55 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 56 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 57 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 58 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.4 SEQUENCING
7.4.1 NGS TECHNOLOGY RAPIDLY BECOMING AN INDISPENSABLE AND UNIVERSAL TOOL FOR BIOLOGICAL RESEARCH
TABLE 59 SEQUENCING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 60 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 61 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 62 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 63 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.5 BIOINFORMATICS
7.5.1 INCREASING USE OF BIOINFORMATICS TECHNOLOGY DUE TO THE RISING NEED FOR DATA MANAGEMENT AND CURATION
TABLE 64 BIOINFORMATICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 65 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 66 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 67 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 68 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.6 CLONING
7.6.1 CLONING AIDS IN BUILDING NEW GENETIC MODULES/PATHWAYS ENABLING RAPID ADVANCES IN RESEARCH ACROSS INDUSTRIES
TABLE 69 CLONING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 70 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 71 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 72 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 73 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.7 SITE-DIRECTED MUTAGENESIS
7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES DRIVING THE SEGMENT GROWTH
TABLE 74 SITE-DIRECTED MUTAGENESIS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 75 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 76 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 77 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 78 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.8 MEASUREMENT & MODELING
7.8.1 COMPUTATIONAL MODELING TO AID THE GROWTH OF THE SEGMENT DURING THE FORECAST PERIOD
TABLE 79 MEASUREMENT & MODELING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 80 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 81 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 82 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 83 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.9 MICROFLUIDICS
7.9.1 DROPLET MICROFLUIDICS GAINING WIDE RECOGNITION IN THE FIELD OF SYNTHETIC BIOLOGY
TABLE 84 MICROFLUIDICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 85 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 86 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 87 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 88 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.1 NANOTECHNOLOGY
7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY AIDS IN BUILDING COMPLEX BODIES
TABLE 89 NANOTECHNOLOGY: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 90 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 91 EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 92 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 93 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION (Page No. - 137)
8.1 INTRODUCTION
TABLE 94 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
8.2 MEDICAL APPLICATIONS
TABLE 95 MEDICAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 96 MEDICAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 97 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 98 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 99 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 100 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.1 PHARMACEUTICALS
8.2.1.1 Potential of synthetic biology techniques in the development and manufacturing of APIs and small molecules drives the growth of the segment
TABLE 101 PHARMACEUTICALS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 102 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 103 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 104 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 105 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.2 DRUG DISCOVERY AND THERAPEUTICS
TABLE 106 DRUG DISCOVERY AND THERAPEUTICS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 107 DRUG DISCOVERY AND THERAPEUTICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 108 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 109 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 110 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 111 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.2.1 Cancer detection & diagnostics
8.2.2.1.1 Increasing investments in cancer research to drive the growth of the segment
TABLE 112 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY REGION, 20192026 (USD MILLION)
TABLE 113 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 114 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 115 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 116 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.2.2 Other drug discovery and therapeutic applications
TABLE 117 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY REGION, 20192026 (USD MILLION)
TABLE 118 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 119 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION,20192026 (USD MILLION)
TABLE 120 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 121 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3 ARTIFICIAL TISSUE & TISSUE REGENERATION
TABLE 122 ARTIFICIAL TISSUE & TISSUE REGENERATION: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 123 ARTIFICIAL TISSUE & TISSUE REGENERATION: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 124 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 20192026 (USD MILLION)
TABLE 125 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 126 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 127 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3.1 Bio-synthesis
8.2.3.1.1 Bio-synthesis dominating the market with its increasing adoption for creating artificial genomes
TABLE 128 SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY REGION, 20192026 (USD MILLION)
TABLE 129 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 130 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 131 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 132 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3.2 Stem cell regulation
8.2.3.2.1 Use of synthetic biology in stem cell regeneration and reprogramming somatic cells to drive the market growth
TABLE 133 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 20192026 (USD MILLION)
TABLE 134 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 20192026 (USD MILLION)
TABLE 135 EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 136 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 137 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3.3 Other artificial tissue and tissue regeneration applications
TABLE 138 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY REGION, 20192026 (USD MILLION)
TABLE 139 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 140 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 141 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 142 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3 INDUSTRIAL APPLICATIONS
TABLE 143 INDUSTRIAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 144 INDUSTRIAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 145 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 146 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 147 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 148 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.1 BIOFUEL AND RENEWABLE ENERGY
8.3.1.1 Advantages of using genetically engineered organisms for the synthetic production of biofuels driving the market growth
TABLE 149 SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY REGION, 20192026 (USD MILLION)
TABLE 150 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 151 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 152 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 153 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2 INDUSTRIAL ENZYMES
TABLE 154 INDUSTRIAL ENZYMES: SYNTHETIC BIOLOGY MARKET, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 155 INDUSTRIAL ENZYMES: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 156 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 20192026 (USD MILLION)
TABLE 157 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 158 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 159 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.1 Textile industry
8.3.2.1.1 Synthetic biology to replace traditional raw materials in the textile industry
TABLE 160 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 20192026 (USD MILLION)
TABLE 161 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 162 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 163 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 164 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.2 Paper industry
8.3.2.2.1 Increasing use of enzymes in the pulp and paper industry
TABLE 165 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 20192026 (USD MILLION)
TABLE 166 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 167 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 168 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 169 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.3 Consumer care industry
TABLE 170 CONSUMER CARE INDUSTRY: SYNTHETIC BIOLOGY MARKET BY TYPE, 20192026 (USD MILLION)
TABLE 171 CONSUMER CARE INDUSTRY: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 172 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 173 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 174 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 175 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.3.1 Skincare & cosmetics
8.3.2.3.1.1 Enzymes in skincare cosmetics protect skin from harmful external agents causing the breakdown of collagen
TABLE 176 SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY REGION, 20192026 (USD MILLION)
TABLE 177 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 178 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 179 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 180 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.3.2 Other consumer care products
TABLE 181 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 20192026 (USD MILLION)
TABLE 182 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 183 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 184 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 185 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.4 Other industries
TABLE 186 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 20192026 (USD MILLION)
TABLE 187 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 20192026 (USD MILLION)
TABLE 188 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 189 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 190 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.3 BIOMATERIALS & GREEN CHEMICALS
8.3.3.1 Use of synthetic biology for preparing silk-based proteins
TABLE 191 BIOMATERIALS AND GREEN CHEMICALS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 192 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 193 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 194 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 195 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.4 FOOD & AGRICULTURE
8.4.1 SYNTHETIC BIOLOGY TECHNIQUES PRODUCE METABOLITES, HEALTH PRODUCTS, AND PROCESSING AIDS IN THE FOOD AND AGRICULTURE INDUSTRY
TABLE 196 FOOD AND AGRICULTURE: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 197 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY, 20192026 (USD MILLION)
TABLE 198 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 199 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 200 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.5 ENVIRONMENTAL APPLICATIONS
TABLE 201 ENVIRONMENTAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 202 ENVIRONMENTAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 203 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 204 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 205 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 206 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.5.1 BIOREMEDIATION
8.5.1.1 Bioremediation helps in cleaning oil spills, preventing chemical pollution, and plugging nuclear leakages
TABLE 207 SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION, 20192026 (USD MILLION)
TABLE 208 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 20192026 (USD MILLION)
TABLE 209 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 210 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 211 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.5.2 BIOSENSING
8.5.2.1 Biosensors utilize microalgae due to high reproductive rates and ease of culturing
TABLE 212 SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY REGION, 20192026 (USD MILLION)
TABLE 213 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 214 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 215 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 216 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY/REGION, 20192026 (USD MILLION)
9 SYNTHETIC BIOLOGY MARKET, BY REGION (Page No. - 193)
9.1 INTRODUCTION
TABLE 217 SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SNAPSHOT
TABLE 218 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 219 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 220 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 221 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 222 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 223 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 224 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 225 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 226 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 227 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 228 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.2.1 US
9.2.1.1 The US to dominate the North American synthetic biology market
TABLE 229 US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 230 US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 231 US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 232 US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 233 US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 234 US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 235 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 236 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 237 US: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 238 US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Strong research infrastructure and availability of funding to support market growth
TABLE 239 CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 240 CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 241 CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 242 CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 243 CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 244 CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 245 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 246 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 247 CANADA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 248 CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3 EUROPE
TABLE 249 EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 250 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 251 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 252 EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 253 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 254 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 255 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 256 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 257 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 258 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 259 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 The rapidly growing pharmaceutical market to drive the market growth
TABLE 260 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 261 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 262 GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 263 GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 264 GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 265 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 266 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 267 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 268 GERMANY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 269 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.2 UK
9.3.2.1 The UK to hold the largest share of the European market
TABLE 270 UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 271 UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 272 UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 273 UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 274 UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 275 UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 276 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 277 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 278 UK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 279 UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Research across all industries to be strongly supported by the government
TABLE 280 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 281 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 282 FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 283 FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 284 FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 285 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 286 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 287 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 288 FRANCE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 289 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.4 SWITZERLAND
9.3.4.1 Market growth to be primarily driven by the well-established pharmaceutical & biotechnology industry in the country
TABLE 290 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 291 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 292 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 293 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 294 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 295 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 296 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 297 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 298 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 299 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.5 DENMARK
9.3.5.1 Denmark to have the third-largest commercial drug development pipeline in Europe
TABLE 300 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 301 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 302 DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 303 DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 304 DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 305 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 306 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 307 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 308 DENMARK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 309 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.6 ITALY
9.3.6.1 Growth in this market to be mainly driven by increasing life science R&D in the country, funded by both public and private organizations
TABLE 310 ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 311 ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 312 ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 313 ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 314 ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 315 ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 316 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 317 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 318 ITALY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 319 ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.7 SPAIN
9.3.7.1 Spain to have a well-established network of research centers, universities, and hospitals, forming an ideal environment for research
TABLE 320 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 321 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 322 SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 323 SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 324 SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 325 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 326 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 327 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 328 SPAIN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 329 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.8 REST OF EUROPE
TABLE 330 ROE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 331 ROE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 332 ROE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 333 ROE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 334 ROE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 335 ROE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 336 ROE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 337 ROE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 338 ROE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 339 ROE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET SNAPSHOT
TABLE 340 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 341 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 342 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 343 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 344 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 345 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 346 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 347 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 348 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 349 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 350 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Growth in R&D to enhance technological capabilities in the country driving the demand for high-quality research tools
TABLE 351 CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 352 CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 353 CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 354 CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 355 CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 356 CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 357 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 358 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 359 CHINA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 360 CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Large number of research initiatives toward the development of precision medicine supporting the market growth
TABLE 361 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 362 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 363 JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 364 JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 365 JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 366 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 367 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 368 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 369 JAPAN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 370 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.3 AUSTRALIA
9.4.3.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities
TABLE 371 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 372 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 373 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 374 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 375 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 376 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 377 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 378 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 379 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 380 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing pharma R&D activities and government funding for the biotechnology industry driving the market growth
TABLE 381 INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 382 INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 383 INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 384 INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 385 INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 386 INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 387 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 388 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 389 INDIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 390 INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 391 ROAPAC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 392 ROAPAC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 393 ROAPAC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 394 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 395 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 396 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 397 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 398 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 399 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 400 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 401 LATAM: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 402 LATAM: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 403 LATAM: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 404 LATAM: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 405 LATAM: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 406 LATAM: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 407 LATAM: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 408 LATAM: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 409 LATAM: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 410 LATAM: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Growing pharmaceutical industry to drive the market growth
TABLE 411 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 412 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 413 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 414 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 415 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 416 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 417 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 418 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 419 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 420 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Increasing support for biotechnology infrastructure development to drive the market growth
TABLE 421 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 422 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 423 MEXICO: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 424 MEXICO: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 425 MEXICO: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 426 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 427 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 428 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 429 MEXICO: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 430 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 431 ROLA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 432 ROLA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 433 ROLA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 434 ROLA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 435 ROLA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 436 ROLA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 437 ROLA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 438 ROLA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 439 ROLA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 440 ROLA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 INCREASING PARTNERSHIPS AMONG GLOBAL PLAYERS WITH GOVERNMENT ORGANIZATIONS IN THE REGION TO SUPPORT THE MARKET GROWTH
TABLE 441 MEA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 442 MEA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 443 MEA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 444 MEA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 445 MEA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 446 MEA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 447 MEA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 448 MEA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 449 MEA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 450 MEA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 298)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 25 KEY PLAYER STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2018 2021
10.3 MARKET SHARE ANALYSIS
FIGURE 26 SYNTHETIC BIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STAR
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE
10.5.4 EMERGING COMPANIES
FIGURE 28 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 29 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
10.7 COMPANY PRODUCT FOOTPRINT
TABLE 451 PRODUCT PORTFOLIO ANALYSIS: SYNTHETIC BIOLOGY MARKET (2020)
10.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 452 GEOGRAPHIC REVENUE MIX: SYNTHETIC BIOLOGY MARKET (2020)
10.9 COMPETITIVE SCENARIO
10.9.1 SYNTHETIC BIOLOGY MARKET: PRODUCT LAUNCHES, JANUARY 2018 APRIL 2021
10.9.2 SYNTHETIC BIOLOGY MARKET: DEALS, JANUARY 2018APRIL 2021
10.9.3 SYNTHETIC BIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2018 APRIL 2021
11 COMPANY PROFILE (Page No. - 311)
11.1 KEY MARKET PLAYERS
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
11.1.1 THERMO FISHER SCIENTIFIC
FIGURE 30 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.1.2 NOVOZYMES
FIGURE 31 NOVOZYMES: COMPANY SNAPSHOT (2020)
11.1.3 MERCK KGAA
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.4 EUROFINS SCIENTIFIC
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.1.5 AGILENT TECHNOLOGIES
FIGURE 34 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
11.1.6 AMYRIS
FIGURE 35 AMYRIS: COMPANY SNAPSHOT (2020)
11.1.7 CODEXIS
FIGURE 36 CODEXIS: COMPANY SNAPSHOT (2020)
11.1.8 TWIST BIOSCIENCE
FIGURE 37 TWIST BIOSCIENCE: COMPANY SNAPSHOT
11.1.9 GENSCRIPT
FIGURE 38 GENSCRIPT: COMPANY SNAPSHOT (2020)
11.1.10 PRECIGEN
FIGURE 39 PRECIGEN: COMPANY SNAPSHOT (2020)
11.1.11 GINKGO BIOWORKS
11.1.12 SYNTHETIC GENOMICS (SGI)
11.2 OTHER PLAYERS
11.2.1 SYNTHEGO
11.2.2 CREATIVE ENZYMES
11.2.3 CYRUS BIOTECHNOLOGY
11.2.4 ATUM
11.2.5 TESELAGEN
11.2.6 ARZEDA
11.2.7 INTEGRATED DNA TECHNOLOGIES
11.2.8 NEW ENGLAND BIOLABS
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 367)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the synthetic biology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the synthetic biology market. The secondary sources used for this study include Industry Association of Synthetic Biology (IASB), International Association of Synthetic Biology, European Association of Synthetic Biology, Society for Biological Engineering (SBE), Systems and Synthetic Biology Journal, Asian Synthetic Biology Association, Synthetic Biology Engineering Research Center. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the synthetic biology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the synthetic biology business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global synthetic biology market based on the tool, technology, application, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities, and trends)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall synthetic biology market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the synthetic biology market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for this report:
Company Information
- An additional five company profiles
Get in-depth analysis of the COVID-19 impact on the Synthetic Biology Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Synthetic Biology Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Synthetic Biology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Synthetic Biology Market